Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03966404 · ClinicalTrials.gov registry record

EyeBOX Concussion Study and Registry

A clinical trial, sponsored by Oculogica.

Completed
Registry status
200
Enrollment target

NCT03966404 is a clinical trial that has completed, run by Oculogica. The registered enrollment target is 200 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03966404 has completed, sponsored by Oculogica.

COMPLETED
Registry status
200 participants
Enrollment target

Study Summary

The objective of this study is to further evaluate eye movements as an aid in the diagnosis of concussion / mTBI and the utility of eye movement assessment in the monitoring of symptoms over time after an initial diagnosis of concussion.

Interventions

  • DIAGNOSTIC_TEST EyeBOX device

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2019-08-05
Est. Completion 2023-06-01

Sponsor

Oculogica

5 total trials

What the Registry Record Tells You About NCT03966404

The ClinicalTrials.gov registry entry for NCT03966404 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oculogica, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which EyeBOX device is the first listed.

NCT03966404 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03966404 about?

NCT03966404 is a clinical study titled "EyeBOX Concussion Study and Registry". The objective of this study is to further evaluate eye movements as an aid in the diagnosis of concussion / mTBI and the utility of eye movement assessment in the monitoring of symptoms over time after an initial diagnosis of concussion.

What is the current status of trial NCT03966404?

This trial is currently completed. The enrollment target is 200 participants. The study started on 2019-08-05. Estimated completion is 2023-06-01.

What interventions are being tested in trial NCT03966404?

The interventions under investigation include: EyeBOX device (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03966404?

This trial is sponsored by Oculogica, which has 5 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.